Titre : Anatoxine staphylococcique

Anatoxine staphylococcique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Lymph Node Excision
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Anatoxine staphylococcique : Questions médicales les plus fréquentes", "headline": "Anatoxine staphylococcique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Anatoxine staphylococcique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Anatoxine staphylococcique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Toxoïdes", "url": "https://questionsmedicales.fr/mesh/D014121", "about": { "@type": "MedicalCondition", "name": "Toxoïdes", "code": { "@type": "MedicalCode", "code": "D014121", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.691" } } }, "about": { "@type": "MedicalCondition", "name": "Anatoxine staphylococcique", "alternateName": "Staphylococcal Toxoid", "code": { "@type": "MedicalCode", "code": "D013208", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Fiona P Havers", "url": "https://questionsmedicales.fr/author/Fiona%20P%20Havers", "affiliation": { "@type": "Organization", "name": "Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: fhavers@cdc.gov." } }, { "@type": "Person", "name": "Susan Hariri", "url": "https://questionsmedicales.fr/author/Susan%20Hariri", "affiliation": { "@type": "Organization", "name": "Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States." } }, { "@type": "Person", "name": "Nasamon Wanlapakorn", "url": "https://questionsmedicales.fr/author/Nasamon%20Wanlapakorn", "affiliation": { "@type": "Organization", "name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand." } }, { "@type": "Person", "name": "Donchida Srimuan", "url": "https://questionsmedicales.fr/author/Donchida%20Srimuan", "affiliation": { "@type": "Organization", "name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand." } }, { "@type": "Person", "name": "Thaksaporn Thatsanathorn", "url": "https://questionsmedicales.fr/author/Thaksaporn%20Thatsanathorn", "affiliation": { "@type": "Organization", "name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node.", "datePublished": "2022-09-21", "url": "https://questionsmedicales.fr/article/36129636", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12282-022-01400-x" } }, { "@type": "ScholarlyArticle", "name": "Lymph nodes: at the intersection of cancer treatment and progression.", "datePublished": "2023-05-04", "url": "https://questionsmedicales.fr/article/37149414", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.tcb.2023.04.001" } }, { "@type": "ScholarlyArticle", "name": "National Practice Patterns in the Management of the Regional Lymph Node Basin After Positive Sentinel Lymph Node Biopsy for Cutaneous Melanoma.", "datePublished": "2022-08-25", "url": "https://questionsmedicales.fr/article/36006494", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1245/s10434-022-12364-9" } }, { "@type": "ScholarlyArticle", "name": "Management of Bulky Inguinal and Pelvic Lymph Nodes.", "datePublished": "2024-05-18", "url": "https://questionsmedicales.fr/article/38925736", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ucl.2024.03.012" } }, { "@type": "ScholarlyArticle", "name": "[Radiologic evaluation of lymph nodes in cancer patients].", "datePublished": "2023-01-12", "url": "https://questionsmedicales.fr/article/36633653", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00104-022-01802-9" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Mélanges complexes", "item": "https://questionsmedicales.fr/mesh/D045424" }, { "@type": "ListItem", "position": 3, "name": "Produits biologiques", "item": "https://questionsmedicales.fr/mesh/D001688" }, { "@type": "ListItem", "position": 4, "name": "Vaccins", "item": "https://questionsmedicales.fr/mesh/D014612" }, { "@type": "ListItem", "position": 5, "name": "Toxoïdes", "item": "https://questionsmedicales.fr/mesh/D014121" }, { "@type": "ListItem", "position": 6, "name": "Anatoxine staphylococcique", "item": "https://questionsmedicales.fr/mesh/D013208" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Anatoxine staphylococcique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Anatoxine staphylococcique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Anatoxine staphylococcique", "description": "Comment diagnostiquer une infection staphylococcique ?\nQuels tests sont utilisés pour détecter l'anatoxine ?\nQuels symptômes indiquent une infection staphylococcique ?\nComment différencier les types de staphylocoques ?\nQuel rôle joue l'anatoxine dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Anatoxine staphylococcique", "description": "Quels sont les symptômes d'une intoxication par anatoxine ?\nComment se manifestent les infections cutanées staphylococciques ?\nQuels signes indiquent une infection systémique ?\nLes symptômes varient-ils selon le type de staphylocoque ?\nQuels symptômes sont associés à l'anatoxine staphylococcique ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Anatoxine staphylococcique", "description": "Comment prévenir les infections staphylococciques ?\nL'anatoxine staphylococcique est-elle vaccinante ?\nQuelles mesures de prévention en milieu hospitalier ?\nLes personnes à risque doivent-elles se faire vacciner ?\nComment éviter la transmission en milieu communautaire ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Anatoxine staphylococcique", "description": "Quel traitement est recommandé pour une infection staphylococcique ?\nL'anatoxine staphylococcique est-elle un traitement ?\nComment traiter une réaction à l'anatoxine ?\nQuels soins sont nécessaires pour les infections cutanées ?\nQuand utiliser des antibiotiques pour les infections staphylococciques ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Anatoxine staphylococcique", "description": "Quelles complications peuvent survenir avec une infection staphylococcique ?\nL'anatoxine peut-elle provoquer des effets secondaires ?\nQuels sont les risques d'une septicémie staphylococcique ?\nComment gérer les complications d'une infection ?\nLes infections staphylococciques peuvent-elles être chroniques ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Anatoxine staphylococcique", "description": "Quels sont les principaux facteurs de risque d'infection staphylococcique ?\nLes personnes diabétiques sont-elles plus à risque ?\nLes athlètes sont-ils à risque d'infections cutanées ?\nComment l'hygiène influence-t-elle le risque d'infection ?\nLes personnes âgées sont-elles plus vulnérables ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection staphylococcique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter l'anatoxine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques peuvent être utilisés pour détecter des anticorps contre l'anatoxine." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection staphylococcique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent rougeurs, gonflements, douleurs et parfois fièvre." } }, { "@type": "Question", "name": "Comment différencier les types de staphylocoques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques et des analyses génétiques aident à identifier les espèces." } }, { "@type": "Question", "name": "Quel rôle joue l'anatoxine dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'anatoxine est utilisée pour évaluer la réponse immunitaire aux infections staphylococciques." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication par anatoxine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des nausées, vomissements et diarrhées." } }, { "@type": "Question", "name": "Comment se manifestent les infections cutanées staphylococciques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles se manifestent par des furoncles, des abcès et des éruptions cutanées." } }, { "@type": "Question", "name": "Quels signes indiquent une infection systémique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, frissons, et signes de septicémie peuvent indiquer une infection systémique." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de staphylocoque ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon la souche et le site d'infection." } }, { "@type": "Question", "name": "Quels symptômes sont associés à l'anatoxine staphylococcique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des réactions allergiques et des douleurs au site d'injection." } }, { "@type": "Question", "name": "Comment prévenir les infections staphylococciques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et désinfecter les blessures aide à prévenir les infections." } }, { "@type": "Question", "name": "L'anatoxine staphylococcique est-elle vaccinante ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée pour immuniser contre certaines infections staphylococciques." } }, { "@type": "Question", "name": "Quelles mesures de prévention en milieu hospitalier ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des protocoles stricts d'hygiène et de désinfection sont essentiels en milieu hospitalier." } }, { "@type": "Question", "name": "Les personnes à risque doivent-elles se faire vacciner ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes à risque d'infections staphylococciques devraient envisager la vaccination." } }, { "@type": "Question", "name": "Comment éviter la transmission en milieu communautaire ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le partage d'objets personnels et maintenir une bonne hygiène personnelle." } }, { "@type": "Question", "name": "Quel traitement est recommandé pour une infection staphylococcique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques sont souvent prescrits, selon la sensibilité de la souche." } }, { "@type": "Question", "name": "L'anatoxine staphylococcique est-elle un traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, c'est un toxoïde utilisé pour la prévention, pas pour le traitement." } }, { "@type": "Question", "name": "Comment traiter une réaction à l'anatoxine ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les réactions allergiques peuvent nécessiter des antihistaminiques ou des corticostéroïdes." } }, { "@type": "Question", "name": "Quels soins sont nécessaires pour les infections cutanées ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un drainage des abcès et des soins locaux sont souvent nécessaires." } }, { "@type": "Question", "name": "Quand utiliser des antibiotiques pour les infections staphylococciques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques sont utilisés lorsque l'infection est confirmée et nécessite un traitement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une infection staphylococcique ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections profondes, des septicémies et des chocs toxiques." } }, { "@type": "Question", "name": "L'anatoxine peut-elle provoquer des effets secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des douleurs au site d'injection et des réactions allergiques peuvent survenir." } }, { "@type": "Question", "name": "Quels sont les risques d'une septicémie staphylococcique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La septicémie peut entraîner des défaillances organiques et un risque accru de mortalité." } }, { "@type": "Question", "name": "Comment gérer les complications d'une infection ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une prise en charge rapide avec des antibiotiques et des soins intensifs est cruciale." } }, { "@type": "Question", "name": "Les infections staphylococciques peuvent-elles être chroniques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent devenir chroniques et nécessiter un traitement prolongé." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection staphylococcique ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent un système immunitaire affaibli, des interventions chirurgicales et des blessures." } }, { "@type": "Question", "name": "Les personnes diabétiques sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète augmente le risque d'infections staphylococciques en raison de la circulation sanguine altérée." } }, { "@type": "Question", "name": "Les athlètes sont-ils à risque d'infections cutanées ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les athlètes peuvent être à risque en raison de blessures et de contacts fréquents." } }, { "@type": "Question", "name": "Comment l'hygiène influence-t-elle le risque d'infection ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise hygiène augmente le risque d'infections staphylococciques, surtout dans les milieux communautaires." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli." } } ] } ] }

Sources (7894 au total)

Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node.

Little is known about the host-tumor interaction in the lymph-node basin at a single cell level. This study examines single cell sequences in breast cancer nodal metastases of a patient with triple-ne... The primary breast tumor, sentinel lymph node, an adjacent lymph node with metastatic involvement and a clinically normal-appearing lymph node were collected during surgery. Single-cell sequencing was... 14,016 cells were clustered into 6 cell subpopulations. Cancer cells demonstrated the molecular characteristics of TNBC basal B subtype and highly expressed genes in the MAPK signaling cascade. Tumor-... Single-cell sequencing analysis suggested that the sentinel lymph node was the initial meeting site of tumor infiltration and immune response, where partial T lymphocytes perform anti-tumor activity, ...

National Practice Patterns in the Management of the Regional Lymph Node Basin After Positive Sentinel Lymph Node Biopsy for Cutaneous Melanoma.

Immediate completion lymph node dissection (CLND) for patients with sentinel lymph node (SLN) metastasis from cutaneous melanoma has been replaced largely by ultrasound nodal surveillance since the pu... Patients with a diagnosis of cutaneous melanoma in 2016 and 2018 without clinical nodal disease who underwent sentinel lymph node biopsy (SLNB) were identified from the National Cancer Database (NCDB)... Of the 3517 patients included in the study, 1405 had disease diagnosed in 2016. The patients with cutaneous melanoma diagnosed in 2016 had a median age of 60 years and a tumor thickness of 2.3 mm comp... The rates of CLND have decreased nationally. However, patients with head/neck primary tumors who live in rural locations are more likely to undergo CLND, highlighting populations for which treatment m...

[Radiologic evaluation of lymph nodes in cancer patients].

In solid tumors, the detection of locoregional lymph node metastases is of decisive importance not only for the prognosis but also for selecting the correct treatment. Various noninvasive imaging meth... This article presents the general principles of noninvasive lymph node diagnostics and discusses the value of the clinically available imaging modalities, ultrasound (US), computed tomography (CT), ma... Literature search and summary of the clinical and scientific experience of the authors.... The available imaging procedures are divided into (1) morphological (US, CT, MRI) and (2) functional modalities (PET, special MRI). The former capture structural lymph node parameters, such as size an... Currently, none of the available modalities have sufficient accuracy to replace lymph node dissection in all oncological scenarios. One of the major challenges for interdisciplinary oncological resear...

Histology of metastatic colorectal cancer in a lymph node.

A primary colorectal cancer (CRC) tumor can contain heterogeneous cancer cells. As clones of cells with different properties metastasize to lymph nodes (LNs), they could show different morphologies. C... Our study enrolled 318 consecutive patients with CRC who underwent primary tumor resection with lymph node dissection between January 2011 and June 2016. 119 (37.4%) patients who had metastatic LNs (m... The histologies of the cancer cells in the mLNs were classified into four types: tubular, cribriform, poorly differentiated, and mucinous. Same degree of pathologically diagnosed differentiation in th... Histology in LNM from CRC might indicate the heterogeneity and malignant phenotype of the disease....

A CT-based radiomics model for predicting lymph node metastasis in hepatic alveolar echinococcosis patients to support lymph node dissection.

Hepatic alveolar echinococcosis (AE) is a severe zoonotic parasitic disease, and accurate preoperative prediction of lymph node (LN) metastasis in AE patients is crucial for disease management, but it... A total of 100 hepatic AE patients who underwent hepatectomy and hepatoduodenal ligament LN dissection at Qinghai Provincial People's Hospital between January 2016 and August 2023 were included in the... A total of 7 radiomics features associated with LN status were selected using LASSO regression. The classification performances of the training set and validation set were consistent, with area under ... In this study, we established and evaluated a radiomics-based prediction model for LN metastasis in patients with hepatic AE using CT imaging. Our findings may provide a valuable reference for clinici...

Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penis.

To evaluate the role of unilateral inguinal lymph-node dissection (ILND) plus contralateral dynamic sentinel node biopsy (DSNB) vs. bilateral ILND in clinical N1 (cN1) penile squamous cell carcinoma (... Within our institutional database (1980-2020, included), we identified 61 consecutive cT1-4 cN1 cM0 patients with histological confirmed peSCC who underwent either unilateral ILND plus DSNB (26) or bi... Median age was 54 years (Interquartile range [IQR]: 48-60 years). Median follow-up was 68 months (IQR 21-105 months). Most patients had pT1 (23 %) or pT2 (54.1%), as well as G2 (47.5%) or G3 (23%) tum... In patients with cN1 peSCC the risk of occult contralateral nodal disease is comparable to cN0 high risk peSCC and the gold standard, namely bilateral ILND, may be replaced by unilateral ILND and cont...

Prediction of the number of positive axillary lymph nodes according to sentinel lymph node involvement and biological subtypes in patients receiving neoadjuvant chemotherapy.

Sentinel lymph node biopsy (SLNB) has replaced axillary lymph node dissection (ALND) for assessing axillary lymph node status in clinically node-negative breast cancer patients. However, the approach ... After NAC, 150 clinically node-negative patients were included. The relationships between clinicopathologic parameters and the number of positive lymph nodes in SLNBs and ALNDs were assessed through b... Among 150 patients, 78 patients had negative SLNBs, and 72 patients had positive SLNBs. According to the ALND data of 21 patients with SLNB1+, there was no additional node involvement (80.8%), 1-2 lym... The number of SLNB-positive nodes, tumor-related parameters, and response to treatment may predict no additional nodes to be positive at ALND....

Hot dots - which nodes should be removed in sentinel lymph node biopsy for melanoma?

Sentinel lymph node biopsy (SLNB) is a critical staging tool for melanoma patients. The optimal number of lymph nodes removed in SLNB remains unclear. In this study, we retrospectively analysed and te... The study population consisted of melanoma patients undergoing SLNB. During the operation all radioactive and blue nodes were removed and sent for histopathological analysis. The... Altogether 175 patients with clinically occult metastasis presented with one or more positive, i.e. metastatic, SLNs. The mean number of lymph nodes removed was 4.5, and the mean number of positive ly... By removing the hottest node and all nodes with radioactivity >10% of the hottest node, 97% of patients with SLN metastases are correctly staged with or without using blue dye....